These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30755439)

  • 61. Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
    Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy.
    Yang L; Shen C; Pettit CJ; Li T; Hu AJ; Miller ED; Zhang J; Lin SH; Williams TM
    Clin Cancer Res; 2020 Jul; 26(14):3740-3750. PubMed ID: 32220892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HDM2 regulation by AURKA promotes cell survival in gastric cancer.
    Sehdev V; Katsha A; Arras J; Peng D; Soutto M; Ecsedy J; Zaika A; Belkhiri A; El-Rifai W
    Clin Cancer Res; 2014 Jan; 20(1):76-86. PubMed ID: 24240108
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ATR inhibition sensitizes HPV
    Leonard BC; Lee ED; Bhola NE; Li H; Sogaard KK; Bakkenist CJ; Grandis JR; Johnson DE
    Oral Oncol; 2019 Aug; 95():35-42. PubMed ID: 31345392
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined AURKA and H3K9 Methyltransferase Targeting Inhibits Cell Growth By Inducing Mitotic Catastrophe.
    Mathison A; Salmonson A; Missfeldt M; Bintz J; Williams M; Kossak S; Nair A; de Assuncao TM; Christensen T; Buttar N; Iovanna J; Huebert R; Lomberk G
    Mol Cancer Res; 2017 Aug; 15(8):984-997. PubMed ID: 28442587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
    Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
    J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design, synthesis and biological activity of N
    Kurup S; McAllister B; Liskova P; Mistry T; Fanizza A; Stanford D; Slawska J; Keller U; Hoellein A
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):74-84. PubMed ID: 29115879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.
    Friedman J; Morisada M; Sun L; Moore EC; Padget M; Hodge JW; Schlom J; Gameiro SR; Allen CT
    J Immunother Cancer; 2018 Jun; 6(1):59. PubMed ID: 29925431
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synergy of WEE1 and mTOR Inhibition in Mutant
    Hai J; Liu S; Bufe L; Do K; Chen T; Wang X; Ng C; Li S; Tsao MS; Shapiro GI; Wong KK
    Clin Cancer Res; 2017 Nov; 23(22):6993-7005. PubMed ID: 28821559
    [No Abstract]   [Full Text] [Related]  

  • 70. Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines.
    Barbosa RSS; Dantonio PM; Guimarães T; de Oliveira MB; Fook Alves VL; Sandes AF; Fernando RC; Colleoni GWB
    Biochem Biophys Res Commun; 2019 Nov; 519(3):597-604. PubMed ID: 31540690
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PDK1 Mediates
    Sambandam V; Frederick MJ; Shen L; Tong P; Rao X; Peng S; Singh R; Mazumdar T; Huang C; Li Q; Pickering CR; Myers JN; Wang J; Johnson FM
    Clin Cancer Res; 2019 Jun; 25(11):3329-3340. PubMed ID: 30770351
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CRISPR/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer.
    Chen A; Wen S; Liu F; Zhang Z; Liu M; Wu Y; He B; Yan M; Kang T; Lam EW; Wang Z; Liu Q
    Cancer Commun (Lond); 2021 Feb; 41(2):121-139. PubMed ID: 33471959
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
    Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
    Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Modulation of oxidative phosphorylation augments antineoplastic activity of mitotic aurora kinase inhibition.
    Zhang Z; Zeng D; Zhang W; Chen A; Lei J; Liu F; Deng B; Zhuo J; He B; Yan M; Lei X; Wang S; Lam EW; Liu Q; Wang Z
    Cell Death Dis; 2021 Sep; 12(10):893. PubMed ID: 34593753
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.
    Chen X; Low KH; Alexander A; Jiang Y; Karakas C; Hess KR; Carey JPW; Bui TN; Vijayaraghavan S; Evans KW; Yi M; Ellis DC; Cheung KL; Ellis IO; Fu S; Meric-Bernstam F; Hunt KK; Keyomarsi K
    Clin Cancer Res; 2018 Dec; 24(24):6594-6610. PubMed ID: 30181387
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia.
    Katsha A; Soutto M; Sehdev V; Peng D; Washington MK; Piazuelo MB; Tantawy MN; Manning HC; Lu P; Shyr Y; Ecsedy J; Belkhiri A; El-Rifai W
    Gastroenterology; 2013 Dec; 145(6):1312-22.e1-8. PubMed ID: 23993973
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma.
    Conway PJ; De La Peña Avalos B; Dao J; Montagnino S; Kovalskyy D; Dray E; Mahadevan D
    Neoplasia; 2024 Sep; 55():101014. PubMed ID: 38875929
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma.
    Felgenhauer J; Tomino L; Selich-Anderson J; Bopp E; Shah N
    Neoplasia; 2018 Oct; 20(10):965-974. PubMed ID: 30153557
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of AURKA as a Biomarker Associated with Cuproptosis and Ferroptosis in HNSCC.
    Jia X; Tian J; Fu Y; Wang Y; Yang Y; Zhang M; Yang C; Liu Y
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673957
    [TBL] [Abstract][Full Text] [Related]  

  • 80. FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition.
    Diab A; Gem H; Swanger J; Kim HY; Smith K; Zou G; Raju S; Kao M; Fitzgibbon M; Loeb KR; Rodriguez CP; Méndez E; Galloway DA; Sidorova JM; Clurman BE
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28287-28296. PubMed ID: 33093209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.